Nasdaq · CIK 0001801198
LEGN Legend Biotech Corp
Insider trading from SEC Form 4. Last filing 11 d ago. Close $18.62 on Oct 9, 2026, +12% from the 52-week low and -49% from the high.
Last 90 days
Net insider value
-$309k
more sold than bought
Buys
0
$0 by 0 insiders
Sells
2
$309k by 2 insiders
Insiders on file
8
with a Form 4 at this company
Price and insider trades, last year
LEGNOct 9, 2026 · close 18.62
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
Open-market buys and sells at Legend Biotech Corp, scored.
| Score | Insider | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 46Moderate | Corazon (Corsee) D. Sanders director sell | $259k 27,370 shares | -34% | +13% from low-48% from high | |
| 47Moderate | Carlos E Santos Chief Financial Officer sell | $50k 5,430 shares | -28% | +11% from low-49% from high |
Transactions
The last 10 rows filed, every code.
| Date | Insider | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Sep 29, 2026 | Corazon (Corsee) D. Sanders director | SOpen-market sale Ordinary Shares | -27,370 | $9.46 | $259k | 52,731 | 11 d ago |
| Sep 24, 2026 | Patrick John Casey director | AGrant or award Ordinary Shares | +20,986 | $0.00 | $0 | 69,590 | 14 d ago |
| Sep 24, 2026 | Tomas J. Heyman director | AGrant or award Ordinary Shares | +20,986 | $0.00 | $0 | 53,720 | 14 d ago |
| Sep 24, 2026 | Darren Xiaohui Ji director | AGrant or award Ordinary Shares | +28,330 | $0.00 | $0 | 92,103 | 14 d ago |
| Sep 24, 2026 | Corazon (Corsee) D. Sanders director | AGrant or award Ordinary Shares | +20,986 | $0.00 | $0 | 80,101 | 14 d ago |
| Sep 24, 2026 | Peter Salovey director | AGrant or award Ordinary Shares | +28,330 | $0.00 | $0 | 55,096 | 14 d ago |
| Sep 24, 2026 | Li Mao director | AGrant or award Ordinary Shares | +20,986 | $0.00 | $0 | 65,316 | 14 d ago |
| Sep 21, 2026 | Carlos E Santos Chief Financial Officer | AGrant or award Ordinary Shares | +19,676 | $0.00 | $0 | 19,676 | 19 d ago |
| Sep 21, 2026 | Carlos E Santos Chief Financial Officer | SOpen-market sale Ordinary Shares | -5,430 | $9.14 | $50k | 14,246 | 19 d ago |
| Sep 15, 2026 | Ingrid Zhang Chief Executive Officer | AGrant or award Ordinary Shares | +1,131,860 | $0.00 | $0 | 1,131,860 | 26 d ago |
Insiders
Everyone who has filed a Form 4 here.
- Patrick John Caseydirector
- Tomas J. Heymandirector
- Darren Xiaohui Jidirector
- Li Maodirector
- Peter Saloveydirector
- Corazon (Corsee) D. Sandersdirector
- Carlos E SantosChief Financial Officer
- Ingrid ZhangChief Executive Officer
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.